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Human mitochondrial DNA polymerase (Pol g) is the
sole replicase in mitochondria. Pol g is vulnerable
to nonselective antiretroviral drugs and is increas-
ingly associated with mutations found in patients
with mitochondriopathies. We determined crystal
structures of the human heterotrimeric Pol g holoen-
zyme and, separately, a variant of its processivity
factor, Pol gB. The holoenzyme structure reveals an
unexpected assembly of the mitochondrial DNA
replicase where the catalytic subunit Pol gA interacts
with its processivity factor primarily via a domain that
is absent in all other DNA polymerases. This domain
provides a structural module for supporting both the
intrinsic processivity of the catalytic subunit alone
and the enhanced processivity of holoenzyme. The
Pol g structure also provides a context for interpret-
ing the phenotypes of disease-related mutations in
the polymerase and establishes a foundation for
understanding the molecular basis of toxicity of
anti-retroviral drugs targeting HIV reverse transcrip-
tase.
INTRODUCTION
DNA Pol g, in contrast to the many nuclear DNA polymerases
(DNAPs) that have specialized functions, is solely responsible
for DNA replication and repair in mitochondria. Human mito-
chondrial DNA (mtDNA) codes for a subset of proteins involving
the oxidative phosphorylation electron transfer chain, plus two
ribosomal rRNAs and 22 transfer RNAs (tRNAs) (Anderson
et al., 1981). Accordingly, Pol g is critically important for mtDNA
maintenance, cellular energy supply, and viability. Reduced
activities of Pol g lead to mtDNA depletion and impairment of
cellular metabolism. Mutations affecting the catalytic subunit
Pol gA cause a wide range of genetic syndromes with disease
manifestations such as progressive external ophthalmoplegia
(PEO, a disorder characterized by slow paralysis of external
eye muscle and exercise intolerance), myopathy, epilepsy,312 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.neonatal hypotonia, encephalopathy, and Alpers’ syndrome (a
fatal childhood disease leading to brain and liver failure). In
animal studies, homozygous mice with a proofreading-defective
mutant Pol gA exhibit increased accumulation of point and
deletion mutations in mtDNA, as well as premature aging and
a reduced life span (Trifunovic et al., 2004). To date, Pol g
mutants have been implicated in more than 30 human diseases
(Zeviani and Di Donato, 2004; Chinnery and Zeviani, 2008; Wal-
lace, 2005). The clinical manifestations of many mutations are
perplexing as they can be both autosomal dominant and reces-
sive. Understanding the pathology of mitochondrial disorders
can thus be a challenge.
Human Pol g is known to be more susceptible than nuclear
DNA polymerases to inhibition by certain nucleoside reverse
transcriptase inhibitors (NRTIs) that target HIV; Pol g is therefore
probably responsible for most cellular toxicity of this class of
antiviral drugs. The basis for the high susceptibility of Pol g to
inhibition by NRTIs has thus far been limited to modeling Pol g
with bacteriophage T7 DNAP. The active sites of Pol g and HIV
reverse transcriptase (RT) may exhibit features not found in
nuclear DNAPs. However, drug efficacy against HIV is not well
correlated with cellular toxicity: Some NRTIs (e.g., zalcitabine
[ddC], didanosine [ddI], and stavudine [d4T]) are potent inhibitors
of both HIV RT and Pol g, causing both time-dependent and
dose-dependent decreases in mtDNA content and secondary
cellular toxicity, whereas others (e.g., tenofovir [PMPA] and aba-
cavir [CBV]) are more selective for HIV RT (see review by Kohler
and Lewis, 2007). These observations suggest that significant
differences exist in the kinetics of NRTI incorporation into DNA
by Pol g and HIV RT and/or their active-site architectures.
Such differences can be exploited in the rational design of
more selective antiviral agents.
Pol g, like other DNA replicases, has a catalytic subunit, Pol
gA, which possesses both polymerase and proofreading exonu-
clease activities, and an accessory subunit, Pol gB, which
increases enzyme processivity. Unlike other processivity factors
that enhance processivity by increasing enzyme affinity for
template DNA, Pol gB enhances processivity by simultaneously
accelerating polymerization rate and suppressing exonuclease
activity, in addition to increasing affinity for DNA (Johnson and
Johnson, 2001). Reduced exonuclease activity was suggested
to help maintain the integrity of the replisome at mitochondrial
Table 1. Statistics of Data Analysis and Structural Refinement
Pol g Holoenzyme Pol gB-DI4
Native Se-Met Derivative K2OsO4 Soaked Native
Data Collection
Resolution (A˚) 50.0–3.2 50.0–4.0 50.0–4.0 50.0–3.3
Wavelength (A˚) 0.979 0.979 1.140 1.140
Space group P32 P32 P32 P41
Cell dimensions
a, b, c (A˚) 138.4, 138.4, 226.4 138.94, 138.94, 227.35 139.25, 139.25, 227.70 64.42, 64.42, 260.64
a, b, g (C) 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 120.0 90.0, 90.0, 90.0
Unique reflections 76,667 41,728 41,530 11,917
Completenessa (%) 100 (100) 96.3 (82.4) 94.8 (87.9) 99.2 (94.7)
Redundancy 5.7 (5.7) 3.8 (3.7) 3.9 (3.7) 8.2 (3.8)
RLinear
b 0.09 (1.00) 0.072 (0.658) 0.070 (0.622) 0.167 (0.511)
I/sI 21.5 (2.3) 19.5 (3.0) 23.3 (1.8) 5.8 (2.0)
SAD FOM density modification
on combined phases
0.72 0.35 0.40
Refinement
Rwork
c (%) 28.4 25.7
Rfree
d (%) 30.3 29.4
Number of amino acids 1,850 358
RMS deviations from ideal values
Bond (A˚) 0.0108 0.0090
Angle () 1.97 1.71
a Values in parentheses are for the highest-resolution shell.
bRlinear =
PjIi<I>j/
P
Ii where Ii is the i
th measurement and <I> is the weighted mean of all measurements of I.
cRwork =
P
hkl jFobsðhklÞ  FcalcðhklÞj=
P
hkl jFobsðhklÞj for reflections in the working data set.
dRfree is the same as Rwork for 5% of data randomly omitted from refinement.replication forks (Farge et al., 2007). Structurally, Pol gB resem-
bles class II aminoacyl tRNA synthetases and differs significantly
from other processivity factors, including sliding clamps and thi-
oredoxin. The structural basis for the enhanced DNA synthesis
processivity by Pol gB is unknown.
Two mechanisms of mtDNA synthesis have been proposed. A
conventional synchronous mode where leading and lagging-
strand synthesis occur simultaneously (Yang et al., 2002), and
a displacement mode where synthesis initiating from the OH
origin displaces the parental H strand to form a D loop. Only
when the newly synthesized H strand DNA crosses a second
origin (OL) does initiation of L strand synthesis occur. The
nascent H and L strands are therefore extended asymmetrically
(Clayton, 1982). This model was recently modified to allow initi-
ation of L strand synthesis from a number of origins in addition
to OL (Brown et al., 2005).
Here, we report a crystal structure of human DNA Pol g holo-
enzyme. The holoenzyme is a heterotrimer containing one Pol gA
subunit and a dimeric Pol gB subunit. The Pol gA active-site
domain adopts a canonical polymerase configuration. Between
the pol and exo domains lies a spacer domain containing
a unique fold that interacts primarily with only one Pol gB mono-
mer. This study provides a structural basis for the processivity
enhancement in the holoenzyme by the accessory subunit
Pol gB and lays a foundation for understanding the mechanismsof antiviral drug toxicity and mutant Pol g-related human
diseases.
RESULTS AND DISCUSSION
Structure of the Catalytic Subunit
Successful crystallization of the Pol g holoenzyme required
altered forms of both subunits. An exonuclease-deficient mutant
of Pol gA was crystallized with the deletion mutant Pol gB-DI4,
which lacks a four-helix bundle at the dimer interface (Carrode-
guas et al., 2001; Yakubovskaya et al., 2006). DNA polymerase
activity (see the Supplemental Experimental Procedures and
Figure S1 available online) of the enzymes used for crystallization
is comparable to the activity of the exo holoenzyme containing
wild-type Pol gB (Johnson et al., 2000; Yakubovskaya et al.,
2006). The structure of Pol g was determined to 3.2 A˚ resolution.
Phases were calculated by combining those from single-
wavelength anomalous diffraction using selenomethionine-
substituted Pol gA and osmium-derivatives of holoenzyme,
and molecular replacement using human Pol gB (Fan et al.,
2006) as a search model. Density modification applied to the
initial combined phases significantly improved the quality of
electron density maps; the structure was refined to an Rfactor of
28.4% and Rfree 30.3%. Statistics for data collection and refine-
ment are shown in Table 1.Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc. 313
Figure 1. Structure of Pol g
(A) Structure of Pol gA. The pol domain shows a canonical ‘‘right-hand’’ configuration with thumb (green), palm (red), and fingers (blue) subdomains and the exo
domain (gray). The spacer domain (orange) presents a unique structure and is divided into two subdomains. Domains are shown in a linear form where the
N-terminal domain contains residues 1–170; exo, 171–440; spacer, 476–785; and pol, 441–475 and 786–1239. All figures are made with Pymol (DeLano, 2002).
(B and C) Structure of the heterotrimeric Pol g holoenzyme containing one catalytic subunit Pol gA (orange) and the proximal (green) and distal (blue) monomers of
Pol gB. Pol gA primarily interacts with the proximal monomer of the dimeric Pol gB.The catalytic subunit Pol gA contains domains for exonu-
clease (exo) and polymerase (pol) activities separated by a
linker or spacer. Pol gA adopts the canonical polymerase ‘‘right-
hand’’ configuration with subdomains of ‘‘fingers,’’ ‘‘palm,’’ and
‘‘thumb’’ that bind template DNA and substrate nucleotide tri-
phosphate, as well as catalyze phosphodiester bond formation
(Figure 1A). The conserved aspartic acids, D890 and D1135, are
located in the palm at positions consistent with their known roles
in catalysis.
Although the overall fold of Pol gA confirms its classification as
a member of the Pol I family, many features of Pol gA are clearly314 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.absent in the other enzymes. Most obviously, Pol gA possesses
a large spacer domain (400 residues) between the exo and pol
domains. In light of the atomic structure, it was necessary to
modify the earlier sequence homology-based domain definition
of Pol gA because a portion of the originally assigned spacer is
actually the thumb subdomain (Figure 1).
The spacer domain is spatially far from the exo and pol
domains and connects to them only through the long helices of
the thumb subdomain. The spacer has two obvious subdomains,
a globular intrinsic processivity (IP) subdomain (residues 475–
510 and 571–785) and an extended accessory-interacting
determinant (AID) subdomain (residues 511–570) that reaches
more than 50 A˚ away from the main body of Pol gA (Figure 1).
We will show that the IP subdomain explains the intrinsic proces-
sivity of Pol gA and the AID subdomain forms an important
interface with Pol gB that is essential for increased processivity
of the holoenzyme. A homology search against structures in
the protein data bank yields a Z score of 0.2, suggesting
that the spacer domain has a novel fold (Holm and Sander,
1996).
Holoenzyme Formation and Subunit Interface
In agreement with solution studies (Figure S2), the crystal form of
Pol g is a heterotrimer containing one catalytic Pol gA subunit
(135 kDa) and a dimeric Pol gB-DI4 (2 3 50 kDa) with a subunit
contact area 3500 A˚2. The deleted helical bundle in Pol gB is
distance from the subunit interface and not involved in the
subunit interaction with Pol gA (Figure S3).
The trimeric holoenzyme shows unequal subunit interactions:
Pol gA primarily interacts with only one monomer of the Pol gB
dimer (Figures 1B and 1C). An electron cryomicroscopic analysis
of Pol g at 17A˚ resolution came to a similar conclusion (Yaku-
bovskaya et al., 2007), although the subunit interface, modeled
onto the crystal structure of Pol gB, appears to be different
from that found in the crystal structure of the holoenzyme. The
asymmetrical interactions of Pol gA with the proximal monomer
of the Pol gB dimer suggests that a monomeric accessory
subunit could be fully functional, which is indeed the case for
Drosophila Pol g (Wernette and Kaguni, 1986).
An asymmetric heterotrimer provokes the question whether
the human holoenzyme could also be an A2B2 tetramer, which
could position two polymerases at a replication fork—a neces-
sary requirement for coupling leading- and lagging-strand DNA
synthesis. We thus modeled a tetrameric enzyme, adding
a second Pol gA to the heterotrimer by following the symmetry
operator constraining the Pol gB dimer. The modeled tetramer
reveals steric clashes between the AID subdomains of the two
Pol gAs that preclude formation of an actual A2B2 tetramer.
Although this result could be used as support for the displace-
ment model of mtDNA replication (Clayton, 1982), it should be
noted that a trimeric holoenzyme does not rule out other mech-
anisms for positioning two polymerases at a replication fork
(Yang et al., 2002).
The only contact regions between Pol gA and the distal Pol gB
monomer are a salt bridge (2.8 A˚) between R232 of Pol gA and
E394 of Pol gB (Figure 2E) and a weak van der Waals contact
(5.3 A˚) between Pol gA Q540 and Pol gB R122 (Figure 2G). A
R232G substitution, together with T251I and P587L, has been
reported in a child with neonatal hypotonia and hepatic failure
(Ferrari et al., 2005). Healthy siblings of this patient carried
T251I and P587L, suggesting that the R232G substitution is
associated with disease. This clinical case suggests that either
R232 is critical for Pol gA activity or that the contact between
Pol gA and the distal Pol gB monomer is important for human
holoenzyme function.
In contrast to its limited interaction with the distal monomer,
Pol gA makes extensive interactions with the proximal Pol gB
monomer (Figure 2B). Examination of the subunit interface
shows two major areas of hydrophilic interactions: betweenPol gB R264, K373, and D459 and the Pol gA thumb domain area
(E454-D469, and R579) (Figure 2A) and between Pol gB (D253 and
D277) and Pol gA (K1198, R1208, and R1209). In addition, hydro-
phobic interactions occur between a Pol gB hydrophobic core
(V398-L406, V441-L455) in the C-terminal region and Pol gA AID
subdomain L helix (V543-L558) (Figure 2C). Pol gA AID causes
the steric clash in the modeled A2B2 tetramer; in the absence
of stabilizing hydrophobic forces for a second Pol gA monomer,
the holoenzyme is therefore heterotrimeric. In turn, the modeling
suggests that the hydrophobic interface is dominant in subunit
interaction.
To test this idea, we made four L helix mutants: L549N and
L552N, which reduce hydrophobicity with only minimal structural
alteration, a complete deletion (DL), and K553A (Figures 2C and
2D). The latter change nullifies the electrostatic interaction
between Pol gA K553 and E404 of Pol gB. In the absence of Pol
gB, all mutants exhibited activities comparable to wild-type Pol
gA, demonstrating that the alterations do not disrupt the active
site (Figure 3 and the Supplemental Experimental Procedures).
The L helix is therefore not directly involved in DNA binding, in
agreement with our structural observation that the entire AID
subdomain, which includes the L helix, is connected to the
body of Pol gA by flexible linkers, and would likely be disordered
in the absence of Pol gB.
However, the addition of Pol gB reveals a very different
outcome. In 90 mM salt, the Pol gA DL deletion not only severely
lowers the stimulation by Pol gB, but it also reduces the length of
product DNA (Figure 3). In contrast, the L helix missense mutants
had little effect. At higher ionic strength (190 mM salt), wild-type
Pol gA is inactive but retains considerable activity when com-
plexed to Pol gB. However, holoenzymes containing Pol gA
L549N, L552N, or the DL mutant are completely inactive in
high salt. This salt-dependent reduction of activity strongly
suggests that the mutations disrupt the hydrophobic interactions
between Pol gA and Pol gB. Interestingly, holoenzyme contain-
ing K553A appeared equally active as that of the wild-type;
simply disrupting one electrostatic interaction between Pol gA
and Pol gB therefore has only a minor effect when the hydro-
phobic interactions in this region are preserved. These data
provide strong support to our conclusion that hydrophobic inter-
actions between the Pol gA L helix and the C-terminal domain of
Pol gB are the dominant attractive forces that stabilize the AID
subdomain so that it can support processive DNA synthesis by
the holoenzyme.
Although there is low overall sequence similarity in the Pol gA L
helix, residues involved in the hydrophobic interaction with Pol
gB are conserved and are predicted to be a-helical in the mouse,
Drosophila, and Xenopus proteins (Figure 2D). The hydrophobic
residues on the respective Pol gB proteins are also conserved.
Conservation of interacting residues in both subunits suggests
that all these mitochondrial holoenzymes likely possess a com-
mon subunit interface that involves an AID subdomain.
Interestingly, the spacer containing AID is not only missing in
the nonprocessive DNA polymerases, it is also largely absent
in fungal Pol gA (Figure S4). Perhaps not coincidentally, these
enzymes also lack a Pol gB-type processivity factor. It seems
likely that the ancestor of human Pol gA first acquired a spacer
domain, which then allowed a Pol gB-like protein to interact,Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc. 315
Figure 2. The Major Pol g Subunit Interfaces
(A–C) Pol gA- Pol gB proximal monomer interactions. The distal monomer is omitted for clarity.
(A) Charge-charge interactions between the thumb domain of Pol gA and the C-terminal domain of Pol gB.
(B) L-shaped support between Pol gA and the proximal monomer of Pol gB.
(C) Hydrophobic interactions between the L helix of Pol gA and a hydrophobic core of Pol gB. Mutated residues L549, L552, and K553 are shown.
(D) Sequence alignments of residues involved in hydrophobic interactions between Pol gA and Pol gB.
(E–G) Pol gA- Pol gB distal monomer interactions. The proximal monomer is omitted for clarity.
(E) The salt-bridge (2.8 A˚) between Pol gA R232 and the distal Pol gB E394.
(F) Pol gA-Pol gB distal monomer.
(G) The weak van der Waals interaction (5.3 A˚) between Pol gA and the distal Pol gB monomer.and the interacting domains subsequently co-evolved to
increase the processivity of synthesis.
Processivity of the Holoenzyme
The ability to catalyze processive synthesis is essential for repli-
somal complexes. However, most replicases have little proces-
sivity by themselves, generally synthesizing 15 nt or less per
primer-binding event. Pol gA is somewhat exceptional in that it
can synthesize R100 nt (Graves et al., 1998; Johnson et al.,316 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.2000). However, when bound to their accessory proteins, all
replicases exhibit high processivity, synthesizing thousands of
nucleotides without dissociation (Hori et al., 1979; McHenry
and Kornberg, 1977).
To begin to understand the mechanism of Pol g processivity,
we modeled a Pol g-DNA complex by docking the primer-
template DNA from the T7 DNAP-DNA complex (Brieba et al.,
2004) onto the Pol g holoenzyme after superimposing the
active-site domains of the two polymerases. Despite strong
circumstantial evidence for a bacterial origin of mitochondria, the
catalytic subunit Pol gA is more closely related to bacteriophage
T7 DNAP than to any bacterial replicase. The two active-site
domains show high similarity and superimpose with an rmsd of
2.3 A˚ (Figure S5), which enables modeling an enzyme-DNA
complex with confidence.
The docked DNA is cradled by a positively charged channel
formed by the thumb, palm, and fingers of Pol gA (Figures 4
and 5); this pol domain makes contact with 10 bp of template
DNA that includes the primer terminus. In Pol gA holoenzyme,
the hydrophobic interaction between Pol gB and the L helix of
the AID subdomain exposes a surface on Pol gA containing
a high density of positively charged residues (496KQKKAKKV
KK505, termed the K tract, Figures 4B and 5A). The K tract inter-
acts with the negatively charged phosphodiester backbone of
DNA upstream to that bound in the pol domain, thus increasing
the contact of holoenzyme to DNA to 25 bp (Figure 5A). The
modeled complex reveals no direct contact between Pol gB
and primer-template DNA, suggesting that the increased DNA-
binding affinity of holoenzyme by Pol gB is mediated entirely
through Pol gA. In support of this conclusion, weakening the
hydrophobic interaction between the AID subdomain and Pol
gB, which likely causes additional flexibility of the K tract,
reduces activity and processivity of holoenzyme (Figure 3).
This model now provides a structural basis for the known
increased affinity of holoenzyme, relative to Pol gA, to DNA.
Further evidence supporting the model includes limited prote-
olysis of the holoenzyme with and without primer-template DNA.
Comparison of protease digestion patterns suggests several
regions of Pol g are protected by DNA (Figure 4A). Taking advan-
tage of the fact that both Pol gA and Pol gB are His tagged at
their C termini, western blot analyses with anti-His antibody
Figure 3. Activity of Pol gA Mutants
(A) DNA synthesis activities of Pol gA mutants DL,
L549N, L552N, and K553A were assayed without
or with Pol gB at different ionic strengths. ‘‘Lo’’
and ‘‘Hi’’ denote 90 mM and 190 mM NaCl,
respectively. Denatured products were separated
by electrophoresis on an acrylamide gel.
(B) The purity of Pol gA wild-type and mutant
proteins are shown after SDS-PAGE.
aided identification of proteolytic frag-
ments. Digestion of the catalytic subunit
Pol gA generated three C-terminal major
fragments with apparent molecular
masses of 105 kDa, 77 kDa, and 56 kDa,
and a minor fragment of 84 kDa. The 77
kDa C-terminal fragment is absent when
Pol gB is present, suggesting that the
region around residue 560, correspond-
ing to AID domain L helix of Pol gA, is
involved in subunit interactions. When
holoenzyme is bound to DNA, the inten-
sity of the 84 kDa fragment is significantly
reduced, suggesting that it contains
a DNA-binding site. The DNA-protected
region lies near residue 500, corresponding to the K tract, which
is in good agreement with the modeled Pol g-DNA complex.
Other differentially protease-sensitive bands are apparent in
Figure 4A, but the protected regions cannot be unequivocally
identified.
Although Pol gA and T7 DNAP’s catalytic subunit, gene 5
protein (gp5), have similar active-site domains (Figures 4 and
S5), simply referring to Pol gA as a T7-like DNAP is only partially
correct. Pol gA is more processive than T7 gp5 in the absence
of an accessory protein (Graves et al., 1998; Tabor et al., 1987),
and the corresponding processivity factors are different in
structure and function. E. coli thioredoxin, the processivity
factor for gp5, is a 104 aa monomeric protein, whereas the
dimeric Pol gB contains 970 aa. Functionally, the two accessory
proteins use different mechanisms for processivity enhance-
ment: thioredoxin increases T7 DNAP affinity for primer/
template DNA by decreasing koff without affecting the rate of
nucleotide incorporation, therefore effectively prolonging the
time of each binding event (Huber et al., 1987). In contrast,
Pol gB accelerates the polymerization rate, thereby increasing
the number of nucleotides incorporated per binding event
(Johnson et al., 2000).
The model suggests that the relatively high processivity of Pol
gA in the absence of Pol gB can be attributed to the IP subdo-
main of the spacer, which provides a binding site for the
upstream primer-template DNA duplex (Figure 4B). An IP subdo-
main is not found in T7 gp5 (Figure 4C), precluding significant
DNA synthesis in the absence of thioredoxin. The modeled
DNA-holoenzyme complex can also fully explain the remarkable
ability of Pol gB to increase polymerase and decrease exonu-
clease activity simultaneously. Binding of Pol gB to Pol gA
causes the primer terminus to be preferentially bound in theCell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc. 317
Figure 4. Comparison of a Modeled Pol g-DNA Complex with that of the T7 DNAP-DNA Complex
(A) Limited proteolysis of Pol g visualized after SDS-PAGE by western blot or by Coomassie blue staining.
(B) Modeled Pol g-DNA complex containing Pol gA (shown in ribbons), Pol gB (gray CPK), and a docked DNA (blue ribbons) shows that IP and AID subdomains
enhance DNA binding. Mutations and the region protected by DNA from proteolytic digestion (black arrow) are indicated.
(C) Crystal structure of T7 DNAP-DNA complex containing gp5 (ribbons), thioredoxin (gray CPK), and a primer-template DNA (blue ribbons).pol rather than the exo site, probably because less DNA bending
is required.
Furthermore, Pol gB may function beyond processivity
enhancement and play a role in replisome assembly. Despite it
not contacting DNA directly in the modeled Pol g-DNA complex,
Pol gB is able to bind DNA. This activity, however, appears to
be important only for DNA synthesis on duplex templates.
Changing the positively charged residues 363RKK365 and, sepa-
rately, 328RK329 to alanines abolishes DNA-binding activity.
363RKK365 is part of the I7 loop (residues 356–369) that contains
several positively charged residues; the corresponding region in
threonyl-tRNA synthetase (structurally homologous to Pol gB) is
involved in tRNA binding. Deletion of I7 abolishes Pol gB DNA
binding (Carrodeguas et al., 2001). Nonetheless, mutant Pol
gB-containing holoenzyme retains normal activity in copying
single-stranded DNA (Farge et al., 2007), but is defective in repli-
cating duplex DNA in the presence of SSB and helicase. These
data are consistent with the substitutions lying distant from the
primer-template channel (Figure S3). Other Pol gB mutants are
analyzed in the Supplemental Data.318 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.Structurally, the I7 region in both monomers is disordered in
the apo Pol gB structure, but in the proximal monomer becomes
ordered in the holoenzyme structure. To assess whether the
distal monomer remains disordered because of asymmetrical
interaction between dimer Pol gB with Pol gA or whether it is
due to the loss of the four-helical bundle in the Pol gBDI4
mutant, we crystallized and determined its structure to 3.3 A˚
resolution. Deletion of the helical bundle changed the crystal
packing from that of the wild-type, but the structure still re-
mained a perfect dimer (Figure S6). Aside from the deleted
helical bundle, the structure of Pol gB-DI4 is essentially identical
to that of the wild-type protein. As in the wild-type protein, the
two I7 regions are disordered in Pol gB-DI4, indicating that the
differential folding of the Pol gB loops in the holoenzyme is not
a function of the deletion. Most likely, the ordering of I7 in holo-
enzyme is a direct consequence of the Pol gB proximal monomer
interacting with Pol gA.
Although we do not have sufficient data to model the repli-
some, the electrostatic surface potential of Pol gA is informa-
tive. As expected, the putative DNA-binding channel is lined
with positively charged residues, but the opposite surface of
the protein presents a large negatively charged region near
the exo domain, and the tip of the AID subdomain also
contains four sequential glutamates (535EEEE538, E tract;
Figure 5A). The human mitochondrial helicase, Twinkle, has
a highly positively charged C-terminal region that could
contact one of these regions. If the interaction is through the
negatively charged E tract in the replisome, Twinkle would
be positioned in a location close to that of the 363RKK365
and 328RK329, residues important in Twinkle-dependent repli-
cation of duplex DNA. In support of this idea, the correspond-
ing region in T7 DNAP, the thioredoxin-binding domain,
contacts the C terminus of T7 helicase via charge-charge inter-
Figure 5. Pol gA Charge Distribution and
Mutational Analysis
(A) The electrostatic surface potential of Pol gA
is shown in two views, with positively charged
regions highlighted in blue and negatively charged
regions in red. A primer-template DNA duplex is
modeled with black sticks.
(B) Locations of Pol gmutants. (i) Pol gA mutants in
the DNA-binding channel (class II) are highlighted
in blue. (ii) A split open view of the subunit interface
showing class III mutants (orange) affecting Pol gA
and Pol gB (subscripts denote the proximal and
distal monomer) interaction.
actions, and this interaction is essential
for replisome assembly (Hamdan et al.,
2005).
Distinct Mode of Substrate Binding
Polymerases are classic examples of
enzymes using the induced-fit mecha-
nism to achieve substrate specificity.
The apo form of most DNA Pol I members
adopt an ‘‘open’’ conformation, where
catalytically important residues on the
fingers domain lie some distance away
from the palm active-site residues.
After DNA binding, the fingers domain
undergoes structural changes to the
‘‘closed’’ conformation, enabling the
enzyme to align the important residues
for catalysis and substrate selection. The
desolvation effect generated by the con-
formational changes further enhances
substrate specificity (Fersht, 1985; Pet-
ruska et al., 1986). This mechanism is
utilized by all high-fidelity polymerases
and is apparently absent in error-prone
polymerases. Interestingly, the fingers
domain of apo Pol gA directly abut where
the primer terminus will be positioned,
and apo Pol g thus presents a partially
‘‘closed’’ conformation. Nevertheless,
the catalytically important residues on
the fingers domain are still too far for catalysis, a rotational
conformational change is still necessary after DNA binding to
position the catalytic residues correctly. The configuration of
the Pol gA active site suggests that the conformational change
in the fingers domain is coaxial with the duplex DNA, whereas
it is perpendicular in other DNAPs.
Apo Pol gA further differs from other DNAPs in the active site
by containing a small subdomain (residues 1050–1095) that
partially blocks the DNA-binding channel. This type of subdo-
main has not been described before in other DNAPs, but the
apo form of phage N4 virion miniRNAP contains a similar subdo-
main that rotates out of the channel after DNA binding (Gleghorn
et al., 2008). If Pol g indeed undergoes different conformationalCell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc. 319
changes than other DNAPs when binding DNA, it may then use
different mechanisms to ensure replication fidelity. These differ-
ences could reflect the high susceptibility of Pol g to NRTIs.
Pol g Mutations and Human Diseases
The critical functions of Pol g in mtDNA synthesis may, in part,
rationalize the diversity and progressive effects of Pol g muta-
tions in degenerative human disorders. Many severe human
diseases have been correlated with mutations affecting Pol g
(http://tools.niehs.nih.gov/polg/), and several mutant proteins
have been characterized. Using the Pol g structure, we can
now begin to rationalize the effects of some of these substitu-
tions. Previous mutational analyses using the T7 DNAP structure
as a model have successfully explained mutations predicted to
affect the active site (Graziewicz et al., 2004), and as we have
shown here the active sites of the two proteins are homologous.
However, mutations located in the spacer region—as originally
defined by sequence alignment with E. coli Pol I—show diverse
biochemical behaviors. The structure of Pol g now enables us to
use a structure-based domain definition and distinct subdomain
functions to reanalyze the effects of these mutations.
We divided all reported disease-associated Pol g mutations
into three classes (Table S1). Class I contains active-site muta-
tions that all result in reduced enzyme catalysis; class II includes
substitutions located in the putative DNA-binding channel, thus
reducing DNA-binding affinity directly. Class III contains subunit
interface substitutions that disrupt the subunit interaction
between Pol gA and Pol gB and thus naturally have a reduced
processivity. It should be noted that, although clinically discov-
Figure 6. Structural Differences between
HumanPol g andHIVReverse Transcriptase
Overall structures of the two enzymes illustrate
differences in the interaction between the catalytic
and accessory subunits, and the modes of DNA
binding (A and B). The active site of Pol gA,
comprised of an a-helical fingers domain (C),
differs significantly from that of HIV RT (D), where
the incoming dNTP binding site is comprised of
b sheet fingers.
ered, not all substitutions shown in Table
S1 have been shown biochemically to
adversely affect enzyme activity.
A cluster of substitutions found in PEO
patients (Lamantea et al., 2002; Van Goe-
them et al., 2001), R943H/C, Y955C, and
A957P/S, fall into class I. A modeled Pol
g-DNA complex with an incoming dNTP
(Figure 6C) suggests that R943 may form
a charged interaction with the triphos-
phate moiety. Substitution of the posi-
tively charged arginine should drastically
reduce affinity for incoming nucleotides.
Y955 abuts the templating base, in a
position that is consistent with its known
multifunctional roles in other Pol I fam-
ily enzymes, including primer-template
alignment and substrate selection (Joyce and Benkovic, 2004).
A957 is adjacent to a critical glycine (G958); the equivalent residue
in T7 RNAP (another Pol I family member) serves as a fulcrum
during enzyme translocation and coordinates substrate binding
(Yin and Steitz, 2004). Substitutions of A957 with bulkier residues
likely interfere with both enzyme translocation and binding to an
incoming dNTP. In general, the predicted consequences of all
these mutations are a decreased affinity for dNTPs, increased
error rates and/or reduced catalysis, in good agreement with
solution studies (Graziewicz et al., 2004). Mutations giving rise
to these defective proteins should tend to confer a dominant
phenotype, likely because the mutant enzymes compete effec-
tively with the wild-type enzyme for binding to the template
DNA and cause error-prone DNA synthesis.
Because of the multiple functions of the spacer, the phenotypes
of whathave traditionally been calledspacer mutants vary with the
spatial location of the substitution. Our structure suggests that the
IP and AID subdomains of the spacer use distinct means to
increase processivity: the IP subdomain functions independently
of Pol gB, whereas AID acts only through its interaction with Pol
gB. Accordingly, spacer mutations segregate into classes II and
III, but in general both are likely to have reduced affinity for DNA.
A large number of class II mutations are arginine substitutions
that are distributed along the modeled primer-template DNA
binding channel. Substitution of positively charged arginine
with neutral residues will decrease DNA binding and polymerase
activity. Thus, class II mutants tend to be recessive, as the
mutant Pol gA is ineffective in competing with the wild-type
enzyme for template DNA.320 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.
The class II mutation W748S is commonly associated with
autosomal-recessive ataxia and Alpers’ syndrome (Hakonen
et al., 2005). W748 is located in the IP subdomain (Figures 4B
and 5B), away from the subunit interface, and is likely important
in maintaining the local structure of the IP domain that contacts
the downstream single-stranded DNA. W748 forms stacking-
interaction with F750 and H733 in the local structure. Destabiliza-
tion of this stack by the W748S substitution will undermine the
enzyme’s interaction with template DNA, leading to lower
polymerase activity. This interpretation is consistent with the
biochemical observations of low DNA polymerase activity and
processivity and a severe DNA-binding defect, but normal holo-
enzyme formation (Chan et al., 2006).
The most common substitution among all Pol g mutations,
A467T, is a representative of class III mutants and is associated
with a wide range of mitochondrial disorders (Nguyen et al.,
2005). Biochemical studies using the A467T mutant, which
was thought to affect the spacer domain, unexpectedly was
found to have reduced template binding, and the mutant-con-
taining holoenzyme has lower processivity (Chan et al., 2005;
Luoma et al., 2005), suggesting that the A467T mutant Pol gA
has both reduced polymerase activity and subunit interaction.
This observation can now be explained because the substitu-
tion actually lies in the thumb domain of Pol gA (Figure 4A
and 5B), which is well known to interact with template DNA.
Although Pol gB interacts with the thumb containing A467, this
residue faces away from the interaction surface; A467T may
interrupt the local hydrophobic environment formed by L466
and L602, causing a slight spatial shift of the thumb domain
that interferes with the interaction between the subunits.
The only Pol gB substitution that has been reported to be
associated with disease is G451E, which was found in a single
PEO patient with multiple mtDNA deletions (Longley et al.,
2006). G451E is a class III mutant, as G451 is located near the
interface formed between the C-terminal domain of the prox-
imal Pol gB monomer and the AID subdomain of Pol gA
(Figure 5B). The G451E substitution may cause a steric clash
with T556 on the AID subdomain; perhaps more importantly, it
may disrupt the hydrophobic interaction that is essential for
subunit interaction. This structural analysis agrees with the
biochemical characterization of G451E-substituted Pol gB,
which revealed a compromised subunit interaction and incom-
plete stimulation of catalytic subunit activity (Longley et al.,
2006).
From their structural and biochemical properties, mutations in
class III are expected to be autosomal recessive. A defective
subunit interface leads to reduced polymerase processivity
and DNA binding, defects that can be at least partially compen-
sated in heterozygotes by the presence of wild-type enzyme. In
addition, all class III mutations identified to date are located in the
subunit hydrophilic interface that plays a secondary role in
subunit interaction.
Structural Dissimilarities between Human Pol g and HIV
Reverse Transcriptase Provides Exploitable Space
for Drug Design
Antiviral NRTIs present a unique opportunity for drug design,
because both the target HIV RT and the adverse target humanPol g are known. Although it has long been suspected that the
two enzymes are dissimilar, we can now make detailed structural
comparisons of the human and viral polymerases and exploit
differences in a rational design of antiviral drugs with higher
selectivity.
There are several structural differences between human Pol g
and HIV RT that may be utilized in designing selective inhibitors.
The distinct subunit interactions of the two enzymes result in
substrate DNA being bound in the active site of Pol g at an angle
of 45 to that in HIV RT (Figures 6A and 6B). More importantly,
although the catalytic aspartates of the HIV RT p66 subunit
and Pol gA have a similar spatial arrangement, the incoming
nucleotide-binding sites formed between the palm and fingers
subdomains are structurally distinct. This portion of the fingers
subdomain is a-helical in human Pol g but b sheet in HIV RT
(Figures 6C and 6D).
Both human Pol g and HIV RT utilize electrostatic interactions
of positively charged residues on the fingers domain to bind the
negatively charged triphosphate of an incoming dNTP. How-
ever, their interaction with the nucleoside moiety is different.
In Pol gA, the nucleoside binding site is likely bounded by
E895, Y951, Y955, and Q1102; in HIV RT it is bounded by R72,
F77, Y115, and Q151 (Figures 6C and 6D) (Huang et al., 1998).
Not only is a charge of a residue reversed (E895 in Pol gA versus
R72 in RT) but the positions of Y951 and Y115 are also altered. A
highly conserved bulky residue (a Y or F) in members of the
DNA Pol I family is known to play a major role in discriminating
against incorporation of ddNMP. Pol gA Y951 is located on the
O helix of the fingers domain and has been shown to be
responsible for the lack of discrimination between dNTPs and
ddNTPs (Lim et al., 2003). Y115 of the p66 subunit of HIV RT
has been shown to be important in the discrimination of
30-OH residues (Klarmann et al., 2007) and may be the equiva-
lent residue to Pol gA Y951. However, Y115 in HIV RT p66 lies on
a loop behind the ribose moiety of the incoming dNTP (Figures
6C and 6D). The different angles at which Y951 and Y115
approach the sugar moiety of an incoming dNTP suggest that
they differentially shape the active site and, further, that HIV
RT and Pol g may interact differently with nucleoside analogs.
The HIV RT residue in the equivalent spatial position as Pol
gA Y951 is R72, which actually functions in pyrophosphorolysis
rather than discrimination against the 20-OH of ribose (Sarafia-
nos et al., 1995). The differences between the two enzymes
suggest that it may therefore be possible to design small
molecules that exploit these structural and functional dissim-
ilarities.
The modeled complex of Pol g and DNA also illustrate how
the fingers domain may undergo conformational changes in
order to accommodate the primer/template DNA duplex,
changes that can be contrasted with those in the thumb
domain of HIV RT (Ding et al., 1998; Huang et al., 1998). The
differences may influence how the two enzymes maintain their
different degrees of substrate specificity and their different
responses to nucleoside inhibitors. However, a clearer picture
of how correct and incorrect or analog nucleotides are differen-
tially accommodated within the active sites of HIV RT and Pol
gA must await cocrystal structures of the latter enzyme with
DNA and dNTPs.Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc. 321
EXPERIMENTAL PROCEDURES
Preparation of Pol gA and Pol gB
The His-tagged, exonuclease-deficient (exo) catalytic subunit Pol gA (which
also lacks the mitochondrial localization sequence [residues 1–29] and ten of
13 sequential glutamines [residues 43–52]), was prepared by substitution of
catalytic residues D198 and E200 to alanines. Other mutants were made using
this construct as starting material. Details of these constructions and of the
deletion mutant Pol gB-DI4 are described the Supplemental Data. Pol gA
was expressed in insect Sf9 cells, and Pol gB was expressed in E. coli.
Selenomethionine-substituted Pol gA was produced by a variation of the
procedure of Bellizzi et al. (1999). In brief, Sf9 growth medium (5% FBS in
SF-900 SFM; Invitrogen) was exchanged 12 hr after infection for a methio-
nine-deficient medium containing 5% dialyzed FBS; 7 hr later, the medium
was made 50 mg/L L-(+)-Se-Met (Acros). After 48 hr, cells were harvested
and lysed, and proteins were purified by sequential application to Ni-NTA,
SOURCE S and Superdex 200 columns (Yakubovskaya et al., 2006). Holoen-
zyme was formed by combination of Pol gA and Pol gB monomer at a 1:2 molar
ratio; the complex was then isolated by gel filtration through Superdex 200.
Polymerization Assay
The substrate was single-stranded M13mp18 DNA annealed to a 26 nt primer.
Reaction mixtures contained 50 nM Pol gA (wild-type, L549N, L552N, K553A,
or DL), 100 nM Pol gB (wild-type), and 50 nM primer/template DNA in 20 ml
reaction buffer (10 mM HEPES [pH 7.5], 50 mg/ml BSA, and 3 mM b-mercap-
toethanol). Reactions were initiated by the addition of MgCl2 (10 mM) and
dNTPs (50 mM dGTP, dATP, dTTP, 5 mM dCTP, and 0.1 mM [a-32P]dCTP)
and NaCl (90 or 190 mM) and incubated at 37C for 10 min. Reactions were
stopped by addition of 1% SDS, 20 mM EDTA, and 0.1 mg/ml Protease K
and incubation at 42C for 30 min. Mixtures were then applied to Micro Bio-
Spin 6 columns (Bio-Rad) to remove free nucleotides, heat-denatured at
95C for 5 min in gel loading buffer (70% formamide, 13 TBE, 100 mM
EDTA), and analyzed on a 6% polyacrylamide/7 M urea gel. Reaction products
were visualized by autoradiography.
Crystallography
Crystals of Pol g holoenzyme were grown with the hanging-drop method at
20C at 2–3 mg/mL of the protein complex against a well solution containing
5.5%–7% PEG 8000, 100 mM NaH2PO4, and 100 mM ACES (pH 7.0). Osmium
derivatives were prepared by soaking of crystals in mother liquor containing
3 mM K2OsO4 for 7 hr. Prior to freezing in liquid nitrogen, crystals were trans-
ferred into solutions with stepwise increasing concentrations of glycerol up to
20%. Single-wavelength anomalous diffraction data (SAD) for Se and Os deriv-
atives were collected at Advanced Photon Source 19-ID. All data sets were
processed with the program HKL (Otwinowski and Minor, 1997).
Se atoms (30 out of 34 total) and Os atoms (eight) were located by the anom-
alous difference Fourier method using phases obtained from molecular
replacement with apo Pol gB as a search model. Initial phases (with a figure
of merit of 0.56) were calculated using combined phases from Se-SAD,
Os-SAD, and molecular replacement with the program CNS (Brunger et al.,
1998). Density modification using Solomon in the CCP4 suite (Collaborative
Computational Project N, 1994) was applied to the initial phases; this proce-
dure and B factor sharpening drastically improved the quality of electron-
density maps (Figure S7). The diffraction data of the holoenzyme were initially
indexed to a hexagonal space group P3221 containing one complex per asym-
metric unit (asu). Although the electron-density map was readily interpretable,
the resulting atomic structure could only be refined to a high Rfree (49%). After
careful examination, we reassigned the diffraction data to space group P32
with two copies per asu. In the new space group, diffraction intensity analysis
indicated that the diffraction data were partially twinned with a twinning oper-
ator (h,-h-k,-l) and a twinning factor of 0.46. Refinement was subsequently
carried out in space group P32, with the detwinning procedure in the pro-
gram CNS.
Crystals of Pol gBDI4 were grown by the hanging-drop method at 4C with
10–15 mg/mL protein and a well solution containing 100 mM Tris-HCl
(pH 7–7.5), 100 mM KCl, 6%–8% PEG8000, and 30% glycerol. Crystals
were directly flash frozen in liquid nitrogen. Diffraction data were collected at322 Cell 139, 312–324, October 16, 2009 ª2009 Elsevier Inc.APS 19-ID. The structure was determined by the molecular replacement
method using wild-type human Pol gB as a search model with the program
AMORE (Navaza, 2001) and was refined with Refmac (Winn et al., 2003).
Limited Proteolysis
Experiments were conducted with 20 mg of purified Pol gA, Pol gB-DI4, and
holoenzyme in 20 ml of reaction buffer (20 mM HEPES [pH 7.5], 140 mM KCl,
1 mM EDTA, 5 mM b-mercaptoethanol) with or without equal molar of 25/
45-mer DNA, to which trypsin (0.1 mg) was added. Samples were incubated
on ice for 3 min and treated with an equal volume of 2 3 SDS sample buffer
(125 mM Tris-HCl [pH 6.8], 4% SDS, 20% glycerol, 100 mM DTT) to stop the
digestion reaction. Reaction products were separated by SDS-PAGE; western
blots were performed with anti-His antibody according to the manufacturer
Abcam’s protocol.
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